Business Context and Reporting Period
Company: Bone Biologics Corp (BBLG)
Filing Type: Form 8-K (Current Report)
Report Date: March 26, 2025
Event: Announcement of the 2025 Annual Meeting of Stockholders and updated deadlines for shareholder proposals and director nominations.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and meeting logistics.
Material Changes
No material financial changes are reported. The primary change is the scheduling of the 2025 Annual Meeting for May 30, 2025, which is more than 30 days prior to the anniversary of the last annual meeting. Consequently, the standard deadlines for shareholder proposals and director nominations have been superseded.
Guidance, Outlook, and Management Commentary
- Annual Meeting Date: May 30, 2025.
- Proposal Deadline: Due to the meeting date shift, qualified shareholder proposals and director nominations must be received no later than April 11, 2025 (ten calendar days following this report).
- Submission Address: Bone Biologics Corporation, Attention: Corporate Secretary, 2 Burlington Woods Drive, Suite 100, Burlington, MA 01803.
- Future Filings: Detailed proposals and the record date will be included in the Definitive Proxy Statement on Schedule 14A to be filed with the SEC.
Investor Verification Checklist
- Verify the exact record date for the May 30, 2025 Annual Meeting once the Schedule 14A is filed.
- Confirm the specific proposals to be voted on in the upcoming Schedule 14A.
- Ensure any shareholder proposals or director nominations are submitted by the April 11, 2025 deadline to be considered.
- Review the company's Amended and Restated Bylaws for specific formatting requirements for nominations.